These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 2631290

  • 1. Attempts with lipanthyl to improve lipid metabolism during the adaptation period of women taking oral contraceptives.
    Pilishegyi J.
    Ther Hung; 1989; 37(4):225-9. PubMed ID: 2631290
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S, Arora RC, Garg RK, Agarwal N, Nautiyal A.
    Indian J Physiol Pharmacol; 1988 Jan; 32(1):67-71. PubMed ID: 3169963
    [Abstract] [Full Text] [Related]

  • 6. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K.
    Ther Hung; 1990 Jan; 38(4):181-5. PubMed ID: 2094059
    [Abstract] [Full Text] [Related]

  • 7. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

  • 8. Improvement of lipid metabolism with fenofibrate in gynaecological borderline cases.
    Sásdi A.
    Ther Hung; 1990 Feb; 38(4):177-80. PubMed ID: 2094058
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG, Hedlin AM, Cerskus I, Kakis G, Prudham D, Rosenrot P.
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [Abstract] [Full Text] [Related]

  • 10. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 11. Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial.
    Burkman RT, Robinson JC, Kruszon-Moran D, Kimball AW, Kwiterovich P, Burford RG.
    Obstet Gynecol; 1988 Jan; 71(1):33-8. PubMed ID: 3275909
    [Abstract] [Full Text] [Related]

  • 12. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH, Sudik R.
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [Abstract] [Full Text] [Related]

  • 13. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
    Karsay K.
    Ther Hung; 1980 Jan; 28(1):17-20. PubMed ID: 7281074
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 15. Protective role of lipanthyl in women taking oral contraceptives.
    Sásdi A.
    Ther Hung; 1991 Apr; 39(1):44-6. PubMed ID: 1858074
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S, Hilleman D.
    Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR, Gaspard UJ.
    Int J Fertil; 1987 May; 32 Suppl():15-20. PubMed ID: 2906343
    [Abstract] [Full Text] [Related]

  • 18. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
    Guazzelli CA, Lindsey PC, de Araújo FF, Barbieri M, Petta CA, Aldrighi JM.
    Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
    [Abstract] [Full Text] [Related]

  • 20. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.